ASC Industry News
FDA Reports IV Solution Shortage
The FDA has announced a shortage situation for intravenous (IV) solutions, particularly 0.9% sodium chloride injection (saline). The shortage has been triggered by a range of factors including a reported increased demand by hospitals, potentially related to the flu season. The shortage affects product from the three primary manufacturers, Baxter Healthcare, B.Braun Medical, and Hospira. ASCs should monitor the FDA website and contact the manufacturers and GPO for up to date information.
Texas Workers' Compensation 2014 Education Sessions